1473 Prostaglandin E2 and the tumor microenvironment: unleashing the potential of cancer immunotherapy through rational combination therapies

• Anais Elewaut,
• Guillem Estivill,
• Maria Novatchkova,
• Felix Bayerl,
• Lisa Hoffmann-Haas,
• Francesco Andreatta,
• Trung Nguyen,
• Milica Vulin,
• Jan Boettcher,
• Anna Obenauf

Affiliations

Anais Elewaut

1Research Institute of Molecular Pathology, Vienna, Vienna, Austria

Guillem Estivill

1Research Institute of Molecular Pathology, Vienna, Vienna, Austria

Maria Novatchkova

1Research Institute of Molecular Pathology, Vienna, Vienna, Austria

Felix Bayerl

2Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany

Lisa Hoffmann-Haas

1Research Institute of Molecular Pathology, Vienna, Vienna, Austria

Francesco Andreatta

1Research Institute of Molecular Pathology, Vienna, Vienna, Austria

Trung Nguyen

1Research Institute of Molecular Pathology, Vienna, Vienna, Austria

Milica Vulin

1Research Institute of Molecular Pathology, Vienna, Vienna, Austria

Jan Boettcher

2Institute of Molecular Immunology, School of Medicine, Technical University of Munich, Munich, Germany

Anna Obenauf

1Research Institute of Molecular Pathology, Vienna, Vienna, Austria